Cite
Efficacy and safety of tipepidine as adjunctive therapy in children with attention‐deficit/hyperactivity disorder: Randomized, double‐blind, placebo‐controlled clinical trial.
MLA
Dehbozorghi, Sara, et al. “Efficacy and Safety of Tipepidine as Adjunctive Therapy in Children with Attention‐deficit/Hyperactivity Disorder: Randomized, Double‐blind, Placebo‐controlled Clinical Trial.” Psychiatry & Clinical Neurosciences, vol. 73, no. 11, Nov. 2019, pp. 690–96. EBSCOhost, https://doi.org/10.1111/pcn.12913.
APA
Dehbozorghi, S., Bagheri, S., Moradi, K., Shokraee, K., Mohammadi, M., & Akhondzadeh, S. (2019). Efficacy and safety of tipepidine as adjunctive therapy in children with attention‐deficit/hyperactivity disorder: Randomized, double‐blind, placebo‐controlled clinical trial. Psychiatry & Clinical Neurosciences, 73(11), 690–696. https://doi.org/10.1111/pcn.12913
Chicago
Dehbozorghi, Sara, Sayna Bagheri, Kamyar Moradi, Kamyar Shokraee, Mohammad‐Reza Mohammadi, and Shahin Akhondzadeh. 2019. “Efficacy and Safety of Tipepidine as Adjunctive Therapy in Children with Attention‐deficit/Hyperactivity Disorder: Randomized, Double‐blind, Placebo‐controlled Clinical Trial.” Psychiatry & Clinical Neurosciences 73 (11): 690–96. doi:10.1111/pcn.12913.